Post-Chemo Breast Cancer Treatment

Dr. Ashley Davidson from the Jewish General Hospital attended the Breast Cancer symposium in San Antonio, Texas. Several research papers were presented and here are some of the highlights:

• There is a thought that Tamoxifen could be administered for 2 years and Arimidex could follow for a 3 year period (therefore a 5 year treatment plan). For women who cannot tolerate Tamoxifen - the patient should be started on Arimidex.

• Another thought was to start the patient on Arimidex at the beginning, followed by Tamoxifen especially to women who are low risk, as the research indicated that the overall survival was better.

It's hard to decipher all the statistics but the main focus was taking a look on the current trend of treatment and seeing what happens when a newer approach is tried using the same medications.

I wanted you to know that no matter what kind of cancer you have, there are some very bright individuals who are on the cusp of new discoveries.